The FDA approves a new obesity pill, giving patients another option
Quick Insights
The Bottom Line
FDA approved Foundayo, a daily oral obesity pill, giving patients an injection-free alternative in the weight-loss drug market.
How This Affects You
Patients now have a pill option instead of injections for obesity treatment, though coverage and affordability depend on individual insurance plans.
AI Summary
The FDA has approved Foundayo, a daily oral pill for obesity treatment. The drug received fast-track designation and will compete directly with Wegovy's pill form as an injection-free alternative in the obesity medication market.
What's Being Done
The FDA approved the drug with fast-track designation.
Source Coverage Map
6 of 43 tracked sources covered this story
Following this story?
Get notified when new coverage appears
Other Sources Covering This Story
5 sourcesMultiple outlets have reported on this story. Compare perspectives from different sources.
This article is part of a story we're tracking:
Should this be getting more attention?
You Might Have Missed
Related stories from different sources and perspectives
HealthFDA grants speedy approval to Eli Lilly's weight-loss pill for obesity
The Food and Drug Administration's decision Wednesday means patients in the United States will soon have access to a second daily oral medication to treat obesity and weight-related issues.
HealthUS approves new oral weight-loss pill developed by Eli Lilly
<p>Called Foundayo, the tablet becomes the second one to receive FDA’s green light after Novo Nordisk’s Wegovy</p><p>The US Food and Drug Administration (FDA) gave the green light on Wednesday to a new oral weight-loss medication developed by the Indianapolis-based pharmaceutical company Eli Lilly.</p><p>Known as orforglipron or brand name Foundayo, the once-daily tablet becomes the second GLP-1 drug in pill form to hit the market in a short span of time, arriving after Novo Nordisk’s Wegovy pill received <a href="https://www.theguardian.com/us-news/2025/dec/22/us-regulators-approve-wegovy-weight-loss-pill">approval</a> in December.</p> <a href="https://www.theguardian.com/us-news/2026/apr/01/new-weight-loss-pill-glp-1-foundayo">Continue reading...</a>
PoliticsA Nursing Home Owner Got a Trump Pardon. The Families of His Patients Got Nothing.
The post A Nursing Home Owner Got a Trump Pardon. The Families of His Patients Got Nothing. appeared first on ProPublica .
HealthRecall impacts over 3.1 million eye drop products distributed nationwide: FDA
The FDA said the eye drops were distributed by companies such as Kroger, Walgreens, H-E-B, Military Exchanges, and others.
HealthExclusive: US nicotine pouch fast-track scheme slowed by worries over youth, new users - Reuters
<a href="https://news.google.com/rss/articles/CBMi4AFBVV95cUxQMzd6aVBBemJ4NDgwcGVIWHJBbGY3VlNlUmV3Q0hRdV9tZXQ5YUplZm9HQV9WUDlxTVhPUWs2M0xiYnZRakZyaG9mVFctaUNRdXFvOWFKWnlXRGVjWFRIODhIdjR5UVpTTjlqOEotZklab3hSdDh1bmQ2eDZpNldyOGxPRnZLbXYxcFhURERhOE1wTGlNb01DYUVzNk5kVlZ4b2YzbEUtTDJXUklLLU9VTENsUDhtX21Cek5sU0k5aXprMFdGdmhPRDY5RzlLZzA3VnVMU3VlX0FzV1FjT2h0Qw?oc=5" target="_blank">Exclusive: US nicotine pouch fast-track scheme slowed by worries over youth, new users</a> <font color="#6f6f6f">Reuters</font>
Government TransparencyHow millions in taxpayer dollars are helping fund House members' reelection bids
<p>Keep a close eye on the ads that inundate your screens as the <a href="https://www.axios.com/politics-policy/2026-midterm-elections" target="_blank">2026 midterm elections</a> heat up. You, the taxpayer, paid for some of them.</p><p><strong>Why it matters: </strong>Each election cycle, incumbent House members use a privilege called "franking" to put millions in taxpayer dollars towards giving their reelection campaigns a thinly veiled boost.</p><hr><ul><li>In the 2024 election cycle, House offices spent a combined $44 million on franked mail and another $19 million on other forms of franked communications such as ads, an Axios analysis of congressional disbursement forms found.</li><li>According to the advertising spending tracker AdImpact, around $5 million of that was spent on television and digital ads, which are marked as "paid for with official funds authorized by the House of Representatives."</li><li>Franking is a practice that <a href="https://cha.house.gov/the-history-of...
CDC temporarily halts testing for several infectious diseases amid staffing shortages
<p>Federal agency, which normally supports state and local public health labs, has been hobbled by staff departures</p><ul><li><p><a href="https://www.theguardian.com/news/2026/feb/17/sign-up-for-the-breaking-news-us-email-to-get-newsletter-alerts-direct-to-your-inbox?utm_medium=ACQUISITIONS_STANDFIRST&utm_campaign=BN22326&utm_content=signup&utm_term=standfirst&utm_source=GUARDIAN_WEB">Sign up for the Breaking News US email to get newsletter alerts in your inbox</a></p></li></ul><p>The US federal agency responsible for monitoring diseases has temporarily halted certain diagnostic testing, including those for rabies, human herpesvirus and several other <a href="https://www.theguardian.com/science/infectiousdiseases">infectious illnesses</a>.</p><p>The Centers for Disease Control and Prevention (CDC) released <a href="https://cdc.gov/infectious-diseases-labs/php/test-directory/index.html">a list</a> on Monday showing that more than two dozen types of testing are now un...
Did this story change how you see things?
Stories like this only matter when people see them. Help us get verified journalism in front of more eyes.
The Verity Ledger curates verified investigative journalism from trusted sources only.
See our sourcesMost Read This Week
After 16 years and $8 billion, the military's new GPS software still doesn't work
US paves way for private assets to be included in 401(k) retirement plans - Reuters
Trump administration scales back on asylum crackdown, sources say
European nations warn over Israel’s planned expansion of death penalty
WTO talks near deal on reform roadmap amid US-India e-commerce deadlock - Reuters
